Search results
Harold Eliot Varmus (born December 18, 1939) is an American Nobel Prize-winning scientist. He is currently the Lewis Thomas University Professor of Medicine at Weill Cornell Medicine and a senior associate at the New York Genome Center.
Harold Varmus (born December 18, 1939, Oceanside, New York, U.S.) is an American virologist and cowinner (with J. Michael Bishop) of the Nobel Prize for Physiology or Medicine in 1989 for his work on the origins of cancer.
Biographical. I was born in the shadow of World War II, on December 18, 1939, on the south shore of Long Island, a product of the early twentieth century emigration of Eastern European Jewry to New York City and its environs.
- www.nih.gov
- › About NIH
- › What We Do
- › The NIH Almanac
Oct 22, 2015 · Dr. Harold E. Varmus was nominated to become the 14th director of NIH by President William J. Clinton and was sworn in by HHS Secretary Donna Shalala on November 23, 1993. Winner of the Nobel Prize in 1989 for his work in cancer research (and the first Nobel Laureate to lead the NIH), his appointment was also notable for his lack of any prior ...
Harold E. Varmus. The Nobel Prize in Physiology or Medicine 1989. Born: 18 December 1939, Oceanside, NY, USA. Affiliation at the time of the award: University of California School of Medicine, San Francisco, CA, USA.
The Nobel Prize in Physiology or Medicine 1989 was awarded jointly to J. Michael Bishop and Harold E. Varmus "for their discovery of the cellular origin of retroviral oncogenes".
Laboratory of Harold Varmus. The Varmus Lab at Meyer Cancer Center in Weill Cornell Medicine. The Varmus lab uses several experimental approaches to understand the molecular mechanisms of oncogenesis.
Harold Varmus, M.D., co-recipient of the Nobel Prize for studies of the genetic basis of cancer, joined the Meyer Cancer Center of Weill Cornell Medical College as the Lewis Thomas University Professor of Medicine on April 1, 2015.
Varmus Returns to His Roots in Cancer Genetics. JAMA. 2015 Article GET IT; Evidence that synthetic lethality underlies the mutual exclusivity of oncogenic KRAS and EGFR mutations in lung adenocarcinoma. eLife. 2015 Academic Article GET IT Times cited: 119
Harold E. Varmus Title Professor of Medicine CWID varmus Email varmus@med.cornell.edu Lab Phone +1 646 962 6315 Profiles VIVO
